Orphan Drug, FDA and Korro
In 1983, Congress passed the Orphan Drug Act (“ODA”) as part of an effort to provide market incentives for pharmaceutical manufacturers to produce “orphan drugs,” drugs for diseases that ...
Scientific publications and reach in the field have shown already that post-injury angiogenesis and vascular remodeling ...
Treatments for autoimmune diseases and those in orphan markets are on the up and up, as are drugmakers’ first launches, ...
3d
GlobalData on MSNLundbeck’s amlenetug gains orphan drug status in Japan for MSAAmlenetug is tailored to attach to all major extracellular α-synuclein forms. The human monoclonal antibody aims to prevent ...
With orphan drugs typically being high value, the potential risk of stock losses should be a top concern for biotechs looking ...
PrimeC has been given an ‘Orphan Drug’ status by the FDA (Food and Drug Administration) and EMA (European Medicines Agency).
The FDA granted fast track designation to ATSN-201 for the treatment of X-linked retinoschisis, according to a press release ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results